FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

641000221105: Antigen of Haemophilus influenzae type b capsular polysaccharide conjugated (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
5088464011 Antigen of Haemophilus influenzae type b capsular polysaccharide conjugated en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
5088465012 Antigen of Haemophilus influenzae type b capsular polysaccharide conjugated (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
5088466013 Haemophilus influenzae type b capsular polysaccharide antigen conjugated en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
5088467016 Haemophilus influenzae type b capsular polysaccharide Ag conjugated en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core

5 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antigen of Haemophilus influenzae type b capsular polysaccharide conjugated (substance) Is a Haemophilus influenzae type b antigen true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate antigen conjugated to Clostridium tetani toxoid protein Is a True Antigen of Haemophilus influenzae type b capsular polysaccharide conjugated (substance) Inferred relationship Some
Antigen of Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Corynebacterium diphtheriae cross-reacting material 197 protein (substance) Is a True Antigen of Haemophilus influenzae type b capsular polysaccharide conjugated (substance) Inferred relationship Some
Antigen of Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Neisseria meningitidis serogroup B outer membrane protein (substance) Is a True Antigen of Haemophilus influenzae type b capsular polysaccharide conjugated (substance) Inferred relationship Some
Antigen of Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Corynebacterium diphtheriae toxoid protein (substance) Is a True Antigen of Haemophilus influenzae type b capsular polysaccharide conjugated (substance) Inferred relationship Some
Haemophilus influenzae type b capsular polysaccharide antigen conjugated only vaccine product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Antigen of Haemophilus influenzae type b capsular polysaccharide conjugated (substance) Inferred relationship Some 1
Whole cell Bordetella pertussis and Corynebacterium diphtheriae toxoid and Clostridium tetani toxoid and Haemophilus influenzae type b capsular polysaccharide conjugated antigens only pediatric vaccine The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Antigen of Haemophilus influenzae type b capsular polysaccharide conjugated (substance) Inferred relationship Some 3
Acellular Bordetella pertussis and Corynebacterium diphtheriae toxoid and Clostridium tetani toxoid and Haemophilus influenzae type b capsular polysaccharide conjugated antigens only pediatric vaccine The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Antigen of Haemophilus influenzae type b capsular polysaccharide conjugated (substance) Inferred relationship Some 3
Acellular Bordetella pertussis, Clostridium tetani and Corynebacterium diphtheriae toxoids, Haemophilus influenzae type b capsular polysaccharide conjugated, Hepatitis B virus surface antigens only pediatric vaccine The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Antigen of Haemophilus influenzae type b capsular polysaccharide conjugated (substance) Inferred relationship Some 4
Acellular Bordetella pertussis, Clostridium tetani toxoid, Corynebacterium diphtheriae toxoid, Haemophilus influenzae type b conjugated, Hepatitis B virus and inactivated Human poliovirus antigens only pediatric vaccine product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Antigen of Haemophilus influenzae type b capsular polysaccharide conjugated (substance) Inferred relationship Some 4

Reference Sets

GB English

US English

Back to Start